Literature DB >> 10379007

Arsenic: health effects, mechanisms of actions, and research issues.

C O Abernathy1, Y P Liu, D Longfellow, H V Aposhian, B Beck, B Fowler, R Goyer, R Menzer, T Rossman, C Thompson, M Waalkes.   

Abstract

A meeting on the health effects of arsenic (As), its modes of action, and areas in need of future research was held in Hunt Valley, Maryland, on 22-24 September 1997. Exposure to As in drinking water has been associated with the development of skin and internal cancers and noncarcinogenic effects such as diabetes, peripheral neuropathy, and cardiovascular diseases. There is little data on specific mechanism(s) of action for As, but a great deal of information on possible modes of action. Although arsenite [As(III)] can inhibit more than 200 enzymes, events underlying the induction of the noncarcinogenic effects of As are not understood. With respect to carcinogenicity, As can affect DNA repair, methylation of DNA, and increase radical formation and activation of the protooncogene c-myc, but none of these potential pathways have widespread acceptance as the principal etiologic event. In addition, there are no accepted models for the study of As-induced carcinogenesis. At the final meeting session we considered research needs. Among the most important areas cited were a) As metabolism and its interaction with cellular constituents; b) possible bioaccumulation of As; c) interactions with other metals; d) effects of As on genetic material; e) development of animal models and cell systems to study effects of As; and f) a better characterization of human exposures as related to health risks. Some of the barriers to the advancement of As research included an apparent lack of interest in the United States on As research; lack of relevant animal models; difficulty with adoption of uniform methodologies; lack of accepted biomarkers; and the need for a central storage repository for stored specimens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10379007      PMCID: PMC1566656          DOI: 10.1289/ehp.99107593

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  16 in total

1.  DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.

Authors:  H V Aposhian; A Arroyo; M E Cebrian; L M del Razo; K M Hurlbut; R C Dart; D Gonzalez-Ramirez; H Kreppel; H Speisky; A Smith; M E Gonsebatt; P Ostrosky-Wegman; M M Aposhian
Journal:  J Pharmacol Exp Ther       Date:  1997-07       Impact factor: 4.030

Review 2.  Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity.

Authors:  H V Aposhian
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

3.  Alteration in protein synthesis in primary cultures of rat kidney proximal tubule epithelial cells by exposure to gallium, indium, and arsenite.

Authors:  Y Aoki; M M Lipsky; B A Fowler
Journal:  Toxicol Appl Pharmacol       Date:  1990-12       Impact factor: 4.219

4.  Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan.

Authors:  W P Tseng; H M Chu; S W How; J M Fong; C S Lin; S Yeh
Journal:  J Natl Cancer Inst       Date:  1968-03       Impact factor: 13.506

5.  Arsenic alters cytosine methylation patterns of the promoter of the tumor suppressor gene p53 in human lung cells: a model for a mechanism of carcinogenesis.

Authors:  M J Mass; L Wang
Journal:  Mutat Res       Date:  1997-06       Impact factor: 2.433

6.  A physiologically based pharmacokinetic model for arsenic exposure. II. Validation and application in humans.

Authors:  S Mann; P O Droz; M Vahter
Journal:  Toxicol Appl Pharmacol       Date:  1996-10       Impact factor: 4.219

Review 7.  A chemical hypothesis for arsenic methylation in mammals.

Authors:  D J Thompson
Journal:  Chem Biol Interact       Date:  1993-09       Impact factor: 5.192

8.  A unique metabolism of inorganic arsenic in native Andean women.

Authors:  M Vahter; G Concha; B Nermell; R Nilsson; F Dulout; A T Natarajan
Journal:  Eur J Pharmacol       Date:  1995-12-07       Impact factor: 4.432

9.  Involvement of preferential formation of apurinic/apyrimidinic sites in dimethylarsenic-induced DNA strand breaks and DNA-protein crosslinks in cultured alveolar epithelial cells.

Authors:  K Yamanaka; H Hayashi; K Kato; A Hasegawa; S Okada
Journal:  Biochem Biophys Res Commun       Date:  1995-02-06       Impact factor: 3.575

10.  Drinking water arsenic in Utah: A cohort mortality study.

Authors:  D R Lewis; J W Southwick; R Ouellet-Hellstrom; J Rench; R L Calderon
Journal:  Environ Health Perspect       Date:  1999-05       Impact factor: 9.031

View more
  125 in total

Review 1.  Microbial methylation of metalloids: arsenic, antimony, and bismuth.

Authors:  Ronald Bentley; Thomas G Chasteen
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

Review 2.  State of the science review of the health effects of inorganic arsenic: Perspectives for future research.

Authors:  Paul B Tchounwou; Clement G Yedjou; Udensi K Udensi; Maricica Pacurari; Jacqueline J Stevens; Anita K Patlolla; Felicite Noubissi; Sanjay Kumar
Journal:  Environ Toxicol       Date:  2018-12-04       Impact factor: 4.119

3.  Demethylation of methylarsonic acid by a microbial community.

Authors:  Masafumi Yoshinaga; Yong Cai; Barry P Rosen
Journal:  Environ Microbiol       Date:  2011-01-27       Impact factor: 5.491

4.  Methanogenic inhibition by arsenic compounds.

Authors:  Reyes Sierra-Alvarez; Irail Cortinas; Umur Yenal; Jim A Field
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

5.  Implications of LINE1 methylation for bladder cancer risk in women.

Authors:  Charlotte S Wilhelm; Karl T Kelsey; Rondi Butler; Silvia Plaza; Luc Gagne; M Scot Zens; Angeline S Andrew; Steven Morris; Heather H Nelson; Alan R Schned; Margaret R Karagas; Carmen J Marsit
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

6.  Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice.

Authors:  Nicole V Soucy; Debra Mayka; Linda R Klei; Antonia A Nemec; John A Bauer; Aaron Barchowsky
Journal:  Cardiovasc Toxicol       Date:  2005       Impact factor: 3.231

Review 7.  Human arsenic exposure and risk assessment at the landscape level: a review.

Authors:  Nasreen Islam Khan; Gary Owens; David Bruce; Ravi Naidu
Journal:  Environ Geochem Health       Date:  2009-01-27       Impact factor: 4.609

8.  Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays.

Authors:  Katharina R Beck; Tanja J Sommer; Daniela Schuster; Alex Odermatt
Journal:  Toxicology       Date:  2016-09-28       Impact factor: 4.221

9.  The absence of interleukin-6 enhanced arsenite-induced renal injury by promoting autophagy of tubular epithelial cells with aberrant extracellular signal-regulated kinase activation.

Authors:  Akihiko Kimura; Yuko Ishida; Takashi Wada; Tomoko Hisaoka; Yoshihiro Morikawa; Takeshi Sugaya; Naofumi Mukaida; Toshikazu Kondo
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

10.  Phosphorylation of eukaryotic initiation factor 2 by heme-regulated inhibitor kinase-related protein kinases in Schizosaccharomyces pombe is important for fesistance to environmental stresses.

Authors:  Ke Zhan; Krishna M Vattem; Bettina N Bauer; Thomas E Dever; Jane-Jane Chen; Ronald C Wek
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.